Azione 300878 ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Zhejiang Wecome Pharmaceutical Company Limited

Azioni

300878

CNE1000047P9

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 14/06/2024 		Variaz. 5gg Var. 1 gen.
15,04 CNY -1,38% Grafico intraday di Zhejiang Wecome Pharmaceutical Company Limited -0,20% -40,72%
28/04 Zhejiang Wecome Pharmaceutical Company Limited riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
19/04 Zhejiang Wecome Pharmaceutical Company Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback Plan announced on February 7, 2024.
Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback announced on February 7, 2024, has closed with 2,739,026 shares, representing 1.89% for CNY 50 million.
Zhejiang Wecome Pharmaceutical Company Limited announces an Equity Buyback for CNY 50 million worth of its shares.
Zhejiang Wecome Pharmaceutical Company Limited authorizes a Buyback Plan.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Zhejiang Wecome Pharmaceutical Company Limited are subject to a Lock-Up Agreement Ending on 24-AUG-2023.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Wecome Pharma to Issue $95 Million Convertible Bonds
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Hangzhou Haishan Pharmaceutical Equipment Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Wecome Pharmaceutical Company Limited
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022
Zhejiang Wecome Pharmaceutical Company Limited Approved Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300878
  4. Notizie Zhejiang Wecome Pharmaceutical Company Limited
  5. Altre lingue